Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 21 - 30 of about 169   

Articles published

GSK 1,340.75 +21.25 (1.61%)
price chart
Why GlaxoSmithKline plc Is A Better Dividend Stock Than BP plc
At first glance, it may seem strange to suggest GlaxoSmithKline (LSE: GSK) is a better dividend stock than BP (LSE: BP), as GSK's dividend yield of 5.7% is significantly lower than BP's 6.6%. However, the best dividend stocks are not necessarily the ...
Is GlaxoSmithKline plc's Dividend Safe?
GlaxoSmithKline (LSE: GSK) is often pegged as a super-safe income stock due to the rock solid demand for drugs - and its 5.8% dividend yield - but the fact is this business is in transition and at the moment its payout looks perilously uncovered ...
Better Dividend Stock: GlaxoSmithKline plc vs. AstraZeneca plc  Motley Fool
GlaxoSmithKline plc (ADR) (GSK) Stock Update - Takeover Rumors Drive Recent Gain  Bidness ETC
5 Things GlaxoSmithKline Plc Wants You to Know
Late last month U.K.-based pharmaceutical giant GlaxoSmithKline (NYSE: GSK ) reported its second-quarter results, and for a change they didn't cause investors to run for the hills.
Drug Manufacturers Not to Miss - Heron Therapeutics, Inc. (NASD:HRTX ...
If you owned Pfizer stock when Viagra helped middle-aged men around the globe regain their mojo, you would have enjoyed a decent profit.
GlaxoSmithKline PLC Analyst Rating Update
Analysts at Zacks have given a short term rating of hold on GlaxoSmithKline PLC (NYSE:GSK) with a rank of 3. The shares have received an average rating of 2.63 from 8 brokerage firms.
Recent Analysts' Ratings Changes for GlaxoSmithKline plc (GSK)  Dakota Financial News
Stock in Focus - GlaxoSmithKline PLC (NYSE:GSK)  Vanguard Tribune
British Stocks Trading on US Exchanges: GlaxoSmithKline plc (ADR) (NYSE:GSK ...
UK shares fell more than 2 percent on Tuesday, set for their worst one-day fall in over a week and with miners hit hardest after a slump in the manufacturing sector in China - the world's biggest commodity consumer - rattled global markets.
Do Results Make Hikma Pharmaceuticals Plc A Better Bet Than AstraZeneca plc ...
Who is the real competitor to AstraZeneca (LSE: AZN) and GlaxoSmithKline (LSE: GSK)? In an obvious way they're competing with each other and with the other major blockbuster drug researchers around the world.
GlaxoSmithKline PLC to divest ofatumumab for auto-immune indications to ...
GlaxoSmithKline plc LON:GSK NYSE:GSK today announced an agreement with Novartis Pharma AG, a subsidiary of Novartis AG NYSE:NVS, to divest its rights in ofatumumab for auto-immune indications, including multiple sclerosis.
GSK - GlaxoSmithKline plc: GSK to divest ofatumumab for auto-immune ...  The Wall Street Transcript
Novartis Acquires Rremaining Rghts to GSK's Ofatumumab to Develop ...  Benzinga
GlaxoSmithKline plc 2.3% Potential Upside Indicated by JP Morgan Cazenove
GlaxoSmithKline plc with EPIC/TICKER LON:GSK had its stock rating noted as 'Reiterates' with the recommendation being set at 'UNDERWEIGHT' today by analysts at JP Morgan Cazenove.
Societe Generale Reiterates "Sell" Rating for GlaxoSmithKline plc ...  Dakota Financial News
GlaxoSmithKline plc Rating Reiterated by JPMorgan Chase & Co. (GSK)  The Legacy
GlaxoSmithKline plc 1.9% Potential Upside Indicated by Credit Suisse
GlaxoSmithKline plc with EPIC/TICKER LON:GSK has had its stock rating noted as 'Reiterates' with the recommendation being set at 'UNDERPERFORM' today by analysts at Credit Suisse.
GlaxoSmithKline plc's Underweight Rating Reaffirmed at JPMorgan Chase ...  Dakota Financial News
GlaxoSmithKline plc Stock Rating Reaffirmed by AlphaValue (GSK)  Mideast Time